Ozempic® Lawsuit
Ozempic® and other drugs containing semaglutide have helped many people manage their diabetes and lose weight, but these medications have also been linked to stomach paralysis and other serious health issues. If you became sick after using a semaglutide medication, you may be entitled to financial compensation. Get help with an Ozempic lawsuit now.
Why Take Legal Action?
By filing a dangerous drug lawsuit, you can pursue financial compensation and justice from the companies that caused you or a loved one harm.
Results Secured
- $1.75 million for a woman who suffered a pulmonary embolism from the birth control medication Yaz®
- $1.39 million for a woman in Florida who experienced severe side effects from the arthritis drug Vioxx®
- Over $600,000 for injuries related to Abilify® in New York
Ozempic Lawsuit 2023 Update
Ozempic contains the active ingredient semaglutide, a class of drugs known as GLP-1 receptor agonists (GLP-1 RAs).
Semaglutide acts like the GLP-1 hormone (the hormone released into the gastrointestinal tract when a person eats food). This hormone tells the body to make more insulin, which lowers blood sugar levels. It’s often prescribed to help people manage type 2 diabetes.
In higher amounts, GLP-1 can curb a person’s appetite and create a feeling of fullness. For these reasons, the drugs have helped millions of people battling obesity shed unwanted pounds.
The U.S. Food and Drug Administration (FDA) approved Ozempic for type 2 diabetes in 2017.
Currently, there are three FDA-approved semaglutide drugs:
- Ozempic injection
- Rybelsus tablets
- Wegovy injection
However, the benefits of these dangerous drugs have come at a cost. New studies have shown that Ozempic and other semaglutide medications may lead to an increased risk of serious health conditions.
Researchers at the University of British Columbia connected the medications to three stomach conditions — stomach paralysis, bowel obstruction, and pancreatitis — in nondiabetic patients.
As a result, hundreds of people have filed semaglutide lawsuits seeking financial compensation from the drug makers for failing to warn of the risks associated with their products.
See if you qualify for an Ozempic lawsuit — get a free consultation now.
Health Problems Linked to Ozempic
While many people have experienced positive outcomes from taking Ozempic, users should know of the possible health risks.
Health problems related to Ozempic and semaglutide include:
- Bowel or intestinal obstructions
- Chronic vomiting
- Deep vein thrombosis (DVT)
- Esophageal injury
- Ileus (intestinal inability to contract and pass waste)
- Intraoperative pulmonary aspiration
- Malnutrition-related disorders
- Pancreatic cancer
- Stomach paralysis (gastroparesis)
These health issues can be serious and even life-threatening in some cases. Surgery may even be needed in some instances to help with the side effects. In severe cases, health complications related to Ozempic may lead to wrongful death.
Patients taking Ozempic and Wegovy may also be at a higher risk of developing non-arteritic anterior ischemic optic neuropathy (NAION), a rare eye condition that can cause sudden, painless vision loss in one eye, according to a study published in July 2024 in JAMA Ophthalmology.
Eligibility for an Ozempic Lawsuit
You may qualify to file an Ozempic lawsuit if you or a loved one:
- Used Ozempic, Wegovy, Rybelsus, or another brand of semaglutide product for weight loss
- Later developed serious health issues like stomach paralysis, intestinal obstructions, or more
- Was hospitalized, went to the ER, or needed a follow-up with a gastroenterologist for your injury
Victims took Ozempic, Wegovey, and other semaglutide medications without knowing all of the risks the drugs posed. When drug manufacturers place dangerous medications on the market, they should be made to pay the price for their negligence.
In August 2024, a New Hampshire woman sued the manufacturer of the weight-loss drug Ozempic, alleging that they caused her to develop gastroparesis.
People have a limited amount of time to file an Ozempic lawsuit. Laws called statutes of limitations limit how long a person can file a product liability lawsuit.
These laws differ from state to state. An Ozempic lawyer can tell you about the deadline that applies in your case.
See if you’re eligible for an Ozempic lawsuit — chat with one of our dangerous drug case managers now.
Our case managers can answer your questions and connect you to an attorney.
Chat NowHow to File an Ozempic Semaglutide Lawsuit
The basic steps of an Ozempic lawsuit are listed below.
- Contact an Ozempic lawyer: First, find out if you are eligible for an Ozempic lawsuit by contacting a dangerous drug law firm for a free case evaluation. LawFirm.com can help you get started with a free case review.
- Build a case: Once it’s determined that you have a case, your Ozempic attorney and their team will start collecting evidence to prove your Ozempic claim. This may include your medical records and reports from medical experts.
- File an Ozempic lawsuit: Your lawyer will file your Ozempic lawsuit in the proper court before any legal deadlines and keep you updated as your case proceeds.
- Negotiate a settlement: Your personal injury lawyer will make every effort to negotiate an Ozempic settlement with the parties responsible for your injury, like the maker of the semaglutide medication you used. If a settlement can’t be reached, they will fight for you in court.
Semaglutide Lawsuit Settlements
Most dangerous drug cases end in settlements. Settlements are typically preferred because they give people quicker access to money they may need to pay their medical bills and make up for lost wages.
Additionally, they are less risky since the outcome is predetermined and not based on the opinion of a jury and/or judge.
It’s too early to report a settlement range in these cases. However, the amount of an Ozempic lawsuit settlement will likely depend on various factors.
These factors include:
- The severity of injury
- The amount of related medical expenses
- If the injury will result in permanent disability
- Pain and suffering
Patients who required surgery for their side effects or experienced other serious health problems from Ozempic use are more likely to receive larger settlements.
Get connected with an attorney who may be able to help you file your Ozempic lawsuit — fill out our form for a free case review.
Get Help Filing an Ozempic Lawsuit
If you’ve been diagnosed with stomach paralysis after using Ozempic, Wegovy, or another brand name semaglutide medication, LawFirm.com may be able to help.
We work with law firms that have secured over $1.6 billion for people harmed by negligent drug and pharmaceutical companies.
Our legal partners:
- Can handle cases in all 50 states
- Have the resources to take on powerful drug companies
- Never charge any upfront or out-of-pocket fees
Drug makers should not be able to get away with harming innocent people who relied on their products to improve their health.
Take the first step toward compensation and justice — get a free case evaluation now.
Ozempic Lawsuits FAQs
Can I take Ozempic after gallbladder removal?
Check with your health care provider to see if it’s safe for you to take Ozempic after gallbladder surgery.
That said, Ozempic users should be aware that the semaglutide has been linked to gallbladder problems. In some cases, people needed surgery to remove their gallbladders.
If you used Ozempic and later had your gallbladder removed, a product liability lawyer can review the facts of your case and let you know if you are eligible to file an Ozempic lawsuit.
Can Ozempic cause gallbladder problems?
Yes. Data from the U.S. Food and Drug Administration (FDA) indicates that Ozempic and other semaglutide medications can boost the risk of gallbladder disease and health problems.
In some cases, users have needed to have their gallbladders removed or have suffered other serious health issues.
What are the long-term side effects of Ozempic?
The long-term side effects of Ozempic and other new semaglutide drugs are still being evaluated. However, common side effects reported in clinical trials include abdominal pain, bloating, and vomiting.
Researchers have also found a connection between the diabetes drugs and gallbladder and biliary diseases, especially in people who have used the medications for longer durations.
Who is the maker of semaglutide?
The manufacturer of Ozempic, which is classified as a semaglutide medication, is Novo Nordisk, a Danish pharmaceutical company.
Is there an Ozempic class action lawsuit?
Yes, there’s a class action multidistrict litigation pending in the U.S. District Court for the Eastern District of Pennsylvania for Ozempic and similar weight loss drugs.
As of August 2024, 346 claims have been filed in the Ozempic class action lawsuit. It’s not too late to join the class action and seek compensation.
Call (888) 726-9160 right now to learn about your legal options and see if we can help you get the justice you deserve.
Fact-Checked and Legally Reviewed by: Rae Theodore
Rae Theodore is a writer and editor with more than 30 years of experience in legal publishing. She earned a bachelor’s degree in English from Pennsylvania State University.
- Cleveland Clinic. “Gallstones.” Retrieved August 20, 2024, from https://my.clevelandclinic.org/health/diseases/7313-gallstones
- Cleveland Clinic. “Semaglutide Injection.” Retrieved August 20, 2024, from https://my.clevelandclinic.org/health/drugs/19011-semaglutide-injection
- JAMA. (2023, October 5). “Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss.” Retrieved August 20, 2024, from https://jamanetwork.com/journals/jama/fullarticle/2810542?resultClick=1
- Mass General Brigham. (2024, July 3). “Popular Prescription Weight Loss Drugs Linked to Uncommon Blinding Condition.” Retrieved August 20, 2024, from https://www.massgeneralbrigham.org/en/about/newsroom/press-releases/popular-prescription-weight-loss-drugs-linked-to-uncommon-blinding-condition#
- Mayo Clinic. “Cholecystitis.” Retrieved August 20, 2024, from https://www.mayoclinic.org/diseases-conditions/cholecystitis/symptoms-causes/syc-20364867
- MedPage Today. “FDA Data Link Diabetes Drug Class to Gallbladder Disease.” Retrieved August 20, 2024, from https://www.medpagetoday.com/primarycare/diabetes/100464
- NBCNews.com. “Makers of Ozempic and Mounjaro sued over ‘stomach paralysis’ claims.” Retrieved August 20, 2024, from https://www.nbcnews.com/health/health-news/makers-ozempic-mounjaro-sued-stomach-paralysis-claims-rcna97819
- Reuters. (2023, September 2023). “Wegovy, other weight-loss drugs scrutinized over reports of suicidal thoughts.” Retrieved August 20, 2024, from https://www.reuters.com/business/healthcare-pharmaceuticals/wegovy-other-weight-loss-drugs-scrutinized-over-reports-suicidal-thoughts-2023-09-28/
- Sokolove Law. (2024, August 1). “Ozempic Gallbladder Lawsuit.” Retrieved August 20, 2024, from https://www.sokolovelaw.com/dangerous-drugs/ozempic/
- U.S. Food and Drug Administration. “Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss.” Retrieved August 20, 2024, from https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing-semaglutide-marketed-type-2-diabetes-or-weight-loss
- U.S. Judicial Panel on Multidistrict Litigation. (2024, August 1). “MDL Statistics Report – Distribution of Pending MDL Dockets by District.” Retrieved August 20, 2024, from https://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-August-1-2024.pdf
- Woronow D, Chamberlain C, Niak A, Avigan M, Houstoun M, Kortepeter C. Acute Cholecystitis Associated With the Use of Glucagon-Like Peptide-1 Receptor Agonists Reported to the US Food and Drug Administration. JAMA Intern Med. 2022;182(10):1104–1106. Retrieved August 20, 2024, from doi:10.1001/jamainternmed.2022.3810